Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nerve tissue development" refers to the highly regulated sequence of events by which the nervous system forms during embryogenesis. This includes induction from ectodermal cells via signals from mesoderm-derived structures like the notochord; formation and closure of the neural tube; migration and differentiation into neurons and glial cells; axon guidance via chemotactic cues such as ephrins/Eph receptors; synaptogenesis; myelination by oligodendrocytes in CNS or Schwann cells in PNS; and refinement/remodeling based on electrical activity. Key signaling molecules involved include bone morphogenetic proteins (BMPs), fibroblast growth factors (FGFs), Sonic hedgehog protein (Shh), Notch pathway components, semaphorins, ephrins/Eph receptors among others. Disruptions at any stage can result in congenital neurological disorders or contribute to later neuropsychiatric disease risk[1][2][3][5][7].
Not applicable for the same reason—mechanisms would relate to modulation of underlying signaling pathways like BMP/Smad, FGF/MAPK/ERK, Notch, Sonic hedgehog etc.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve tissue development.